OKYO
Price
$2.39
Change
-$0.21 (-8.08%)
Updated
Nov 13 closing price
Capitalization
89.7M
19 days until earnings call
Intraday BUY SELL Signals
QNCX
Price
$1.68
Change
-$0.03 (-1.75%)
Updated
Nov 13 closing price
Capitalization
89.97M
109 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OKYO vs QNCX

Header iconOKYO vs QNCX Comparison
Open Charts OKYO vs QNCXBanner chart's image
OKYO Pharma
Price$2.39
Change-$0.21 (-8.08%)
Volume$102.39K
Capitalization89.7M
Quince Therapeutics
Price$1.68
Change-$0.03 (-1.75%)
Volume$157.65K
Capitalization89.97M
OKYO vs QNCX Comparison Chart in %
OKYO
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
OKYO vs. QNCX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OKYO is a Hold and QNCX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (OKYO: $2.60 vs. QNCX: $1.71)
Brand notoriety: OKYO and QNCX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OKYO: 74% vs. QNCX: 55%
Market capitalization -- OKYO: $89.7M vs. QNCX: $89.97M
OKYO [@Biotechnology] is valued at $89.7M. QNCX’s [@Biotechnology] market capitalization is $89.97M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OKYO’s FA Score shows that 0 FA rating(s) are green whileQNCX’s FA Score has 0 green FA rating(s).

  • OKYO’s FA Score: 0 green, 5 red.
  • QNCX’s FA Score: 0 green, 5 red.
According to our system of comparison, OKYO is a better buy in the long-term than QNCX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OKYO’s TA Score shows that 4 TA indicator(s) are bullish while QNCX’s TA Score has 5 bullish TA indicator(s).

  • OKYO’s TA Score: 4 bullish, 4 bearish.
  • QNCX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both OKYO and QNCX are a good buy in the short-term.

Price Growth

OKYO (@Biotechnology) experienced а -4.41% price change this week, while QNCX (@Biotechnology) price change was +8.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

OKYO is expected to report earnings on Dec 03, 2025.

QNCX is expected to report earnings on Mar 03, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
QNCX($90M) and OKYO($89.7M) have the same market capitalization . OKYO YTD gains are higher at: 126.107 vs. QNCX (-8.556).
OKYOQNCXOKYO / QNCX
Capitalization89.7M90M100%
EBITDAN/A-41.32M-
Gain YTD126.107-8.556-1,474%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A34.7M-
Total DebtN/A17.5M-
FUNDAMENTALS RATINGS
QNCX: Fundamental Ratings
QNCX
OUTLOOK RATING
1..100
78
VALUATION
overvalued / fair valued / undervalued
1..100
45
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
41
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
OKYOQNCX
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
84%
Momentum
ODDS (%)
Bearish Trend 2 days ago
75%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
68%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
59%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
85%
Declines
ODDS (%)
Bearish Trend 7 days ago
88%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
OKYO
Daily Signal:
Gain/Loss:
QNCX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLVYY3.150.08
+2.61%
Solvay S.A.
BPOSY2.26N/A
N/A
Bpost SA
NTOIF20.18N/A
N/A
Neste OYJ
HSITF0.12N/A
N/A
Hadasit Bio Holdings Ltd.
FRGGF0.36-0.02
-4.03%
Forge Resources Corp.

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and DYN have been poorly correlated (+33% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and DYN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-5.80%
DYN - OKYO
33%
Poorly correlated
-5.39%
XRTX - OKYO
30%
Poorly correlated
-2.06%
NXTC - OKYO
28%
Poorly correlated
+9.04%
QNCX - OKYO
27%
Poorly correlated
-4.47%
MRNA - OKYO
25%
Poorly correlated
+1.14%
More

QNCX and

Correlation & Price change

A.I.dvisor indicates that over the last year, QNCX has been loosely correlated with MNPR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if QNCX jumps, then MNPR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To QNCX
1D Price
Change %
QNCX100%
-4.47%
MNPR - QNCX
35%
Loosely correlated
-1.02%
CCCC - QNCX
33%
Poorly correlated
N/A
ADCT - QNCX
31%
Poorly correlated
+2.02%
CLNN - QNCX
29%
Poorly correlated
-1.47%
KOD - QNCX
28%
Poorly correlated
+3.16%
More